Smart MCs will be participating in the Advanced Therapies Congress 2026, taking place 17–18 March 2026 at ExCeL London. The event brings together researchers, biotech companies, and industry professionals working in the field of advanced therapy medicinal products (ATMPs).
This year, Smart MCs will be represented by our UK & Europe distributor, TCS Biosciences.
Presentation at the Start-ups Showcase
Smart MCs will also be presenting at the Start-ups Showcase (Track 6) during the event.
Presentation Title
Application Tailored and Dissolvable Microcarrier for Large-Scale Adherent Cell and Exosome Manufacturing
Date & Time
Tuesday, 17 March 2026
2:55 PM – 3:15 PM (Europe/London)
The presentation will discuss Smart MCs’ application-tailored microcarriers designed to support large-scale adherent cell culture and exosome production.
Smart MCs Technologies
Smart MCs develops biomaterials and microfluidic technologies designed to support cell culture, biofabrication, and biomanufacturing.
Our product portfolio includes three main areas:
Microcarriers
Designed for adherent cell expansion and scalable cell production.
Hydrogels
Biomaterials that mimic the extracellular matrix (ECM) for 3D cell culture and tissue engineering.
Microfluidic Solutions
Platforms that enable controlled cellular microenvironments for research and bioprocessing applications.
These technologies are used in research areas including cell therapy, regenerative medicine, vaccine development, stem cell research, and cultured meat production.
Meet Our UK & Europe Distributor
If you are attending Advanced Therapies 2026, you can connect with:
Susanna Lovell
TCS Biosciences – Representing Smart MCs
Susanna will be attending the event and available to discuss Smart MCs technologies and potential applications.
Let’s Connect
If you are attending the Advanced Therapies Congress 2026, we look forward to connecting with you in London.
For more information about Smart MCs products, please contact: info@smartmcs.com.au
